Tags

Type your tag names separated by a space and hit enter

Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres.
Eur J Med Chem. 2006 Jan; 41(1):135-41.EJ

Abstract

A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives with various 5- and 6-position bioisosteric substituents (-Cl, -F, -CF3, -CN), namely 1-7, were prepared using a short synthetic route. Each analogue was tested in vitro against the protozoa Giardia intestinalis and Trichomonas vaginalis in comparison with albendazole and metronidazole. Several analogues had IC50 values < 1 microM against both species, which make them significantly more potent than either standard. Compound 4 [2,5(6)-bis(trifluoromethyl)-1H-benzimidazole], was 14 times more active than albendazole against T. vaginalis. This compound (4) also showed moderate antimalarial activity against W2 and D6 strains of Plasmodium falciparum (5.98 and 6.12 microM, respectively). Studying further structure activity relationships through the use of bioisosteric substitution in these benzimidazolic derivatives should provide new leads against protozoal and possibly malarial diseases.

Authors+Show Affiliations

Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca Morelos 62210, México. gabriel_navarrete@uaem.mxNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16260067

Citation

Navarrete-Vázquez, Gabriel, et al. "Synthesis and Antiprotozoal Activity of some 2-(trifluoromethyl)-1H-benzimidazole Bioisosteres." European Journal of Medicinal Chemistry, vol. 41, no. 1, 2006, pp. 135-41.
Navarrete-Vázquez G, Rojano-Vilchis Mde M, Yépez-Mulia L, et al. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres. Eur J Med Chem. 2006;41(1):135-41.
Navarrete-Vázquez, G., Rojano-Vilchis, M. d. e. . M., Yépez-Mulia, L., Meléndez, V., Gerena, L., Hernández-Campos, A., Castillo, R., & Hernández-Luis, F. (2006). Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres. European Journal of Medicinal Chemistry, 41(1), 135-41.
Navarrete-Vázquez G, et al. Synthesis and Antiprotozoal Activity of some 2-(trifluoromethyl)-1H-benzimidazole Bioisosteres. Eur J Med Chem. 2006;41(1):135-41. PubMed PMID: 16260067.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres. AU - Navarrete-Vázquez,Gabriel, AU - Rojano-Vilchis,María de Monserrat, AU - Yépez-Mulia,Lilián, AU - Meléndez,Víctor, AU - Gerena,Lucia, AU - Hernández-Campos,Alicia, AU - Castillo,Rafael, AU - Hernández-Luis,Francisco, Y1 - 2005/11/02/ PY - 2005/05/30/received PY - 2005/09/08/revised PY - 2005/09/08/accepted PY - 2005/11/2/pubmed PY - 2006/5/17/medline PY - 2005/11/2/entrez SP - 135 EP - 41 JF - European journal of medicinal chemistry JO - Eur J Med Chem VL - 41 IS - 1 N2 - A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives with various 5- and 6-position bioisosteric substituents (-Cl, -F, -CF3, -CN), namely 1-7, were prepared using a short synthetic route. Each analogue was tested in vitro against the protozoa Giardia intestinalis and Trichomonas vaginalis in comparison with albendazole and metronidazole. Several analogues had IC50 values < 1 microM against both species, which make them significantly more potent than either standard. Compound 4 [2,5(6)-bis(trifluoromethyl)-1H-benzimidazole], was 14 times more active than albendazole against T. vaginalis. This compound (4) also showed moderate antimalarial activity against W2 and D6 strains of Plasmodium falciparum (5.98 and 6.12 microM, respectively). Studying further structure activity relationships through the use of bioisosteric substitution in these benzimidazolic derivatives should provide new leads against protozoal and possibly malarial diseases. SN - 0223-5234 UR - https://www.unboundmedicine.com/medline/citation/16260067 DB - PRIME DP - Unbound Medicine ER -